This study is now closed to participants. The M22-128 study is evaluating a combination of epcoritamab and lenalidomide for older adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), aiming to improve treatment outcomes and response rates.

The Veterans Affairs Lipid Optimization Reimagined Quality Improvement (VALOR-QI) program aims to improve the treatment of high cholesterol in veterans whose ASCVD puts them at high risk of recurrent heart attack or stroke.

This double-blind drug study enrolls patients currently hospitalized with acute heart failure who will be randomized to Dapagliflozin or placebo treatment arms.

The Reflection study enrolled Veterans who opted to be screened with Galleri, a multi-cancer early detection blood test which can detect the presence of 50+ cancers at time of blood draw.